Ontology highlight
ABSTRACT: Importance
Social media campaigns have been successfully implemented in nontherapeutic trials. However, evidence to support their utility in cancer therapeutic trials is limited.Objective
To examine physician attitudes toward and perceptions of social media use for therapeutic trial recruitment of patients with cancer.Design, setting, and participants
This qualitative study engaged 44 physicians (24 academic based and 20 community based) at the main academic and 6 affiliated community sites of City of Hope in Duarte, California. Semistructured interviews were conducted in person or by telephone from March to June 2018. An interview guide was developed to explore perceptions of social media use for accrual of cancer therapeutic trials. Responses were recorded digitally and transcribed. Data were analyzed using qualitative content analysis.Main outcomes and measures
Physicians' perceptions of the advantages and disadvantages of using social media for clinical trial recruitment, strategies to improve uptake of social media in clinical trials, and the barriers and facilitators to social media use for professional purposes in general.Results
Of the 44 participants, 16 (36%) were women, 30 (68%) had more than 10 years of practice experience, 24 (55%) practiced in academia, and 20 (45%) practiced in the community. Physicians most commonly cited increased trial awareness and visibility as an advantage of using social media for trial recruitment. Cited disadvantages were increased administrative burden and risk of misinformation. Physicians also reported a need for institutional-level interventions (eg, restructuring of clinical trial offices to include personnel with social media expertise), increased evidence-based approaches to social media use, and more physician training on the use of social media. Perceived facilitators to professional social media use were networking and education; barriers included lack of time and lack of evidence of benefit.Conclusions and relevance
In this qualitative study, physicians recognized the benefits of using social media for clinical trial recruitment but noted that barriers, including increased administrative burden, increased time, and the risk of misinformation, remain. Future interventions to address these concerns are a required first step in increasing digital engagement for clinical trial accrual purposes.
SUBMITTER: Sedrak MS
PROVIDER: S-EPMC6751756 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
JAMA network open 20190904 9
<h4>Importance</h4>Social media campaigns have been successfully implemented in nontherapeutic trials. However, evidence to support their utility in cancer therapeutic trials is limited.<h4>Objective</h4>To examine physician attitudes toward and perceptions of social media use for therapeutic trial recruitment of patients with cancer.<h4>Design, setting, and participants</h4>This qualitative study engaged 44 physicians (24 academic based and 20 community based) at the main academic and 6 affilia ...[more]